Professor Kevin Pfleger is Director, Biomedical and Health Innovation at The University of Western Australia (UWA) and the WA Life Sciences Innovation Hub, as well as Head of Molecular Endocrinology and Pharmacology at the UWA Centre for Medical Research (Harry Perkins Institute of Medical Research). He is also Chief Scientific Advisor to Dimerix Limited, an ASX-listed spin-out company from UWA, as well as Scientific Co-Founder of RAGE Biotech. Prof Pfleger was awarded his MA and PhD from Cambridge and Edinburgh Universities respectively, and relocated to Western Australia in October 2002. He was a National Health and Medical Research Council (NHMRC) Peter Doherty Research Fellow from 2005 to 2008, an Australian Research Council (ARC) Future Fellow from 2011 to 2014, and NHMRC RD Wright Fellow (Level 2) from 2015 to 2018. Prof Pfleger was elected as a Fellow of the British Pharmacological Society in 2021.

Director, Biomedical and Health Innovation

Head of Molecular Endocrinology and Pharmacology

Deputy Director Entrepreneurship of the ARC Centre for Personalised Therapeutics Technologies

President of the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT)

Chair of Biodesign Australia

Co-Director of Australian Clinical Entepreneur Program

Member of the International Advisory Group of the British Pharmacological Society

Member of the WA Branch Committee of AusBiotech

Commercialisation Representative on the WAHTN Management Committee

Member of the Life Sciences WA Committee